SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-028784
Filing Date
2024-03-08
Accepted
2024-03-08 17:27:10
Documents
14
Period of Report
2024-03-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-20240308.htm   iXBRL 8-K 44992
2 EX-99.1 xene-ex99_1.htm EX-99.1 13937
3 GRAPHIC img189401473_0.jpg GRAPHIC 5189
  Complete submission text file 0000950170-24-028784.txt   188374

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT xene-20240308.xsd EX-101.SCH 30644
15 EXTRACTED XBRL INSTANCE DOCUMENT xene-20240308_htm.xml XML 4688
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 24735697
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)